0.65p+0.03 (+3.70%)28 Mar 2024, 16:20
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

N4 Pharma PLC Fundamentals

Company NameN4 Pharma PLCLast Updated2024-03-28
IndustryDrug Manufacturers - Specialty & GenericSectorHealthcare
Shares in Issue268.780 mMarket Cap£1.88 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.01EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio1.0372Cash Equity Ratio0.8923
Quick Ratio27.8784Current Ratio27.88
Price To Book Value1.2552ROCE0

N4 Pharma PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

N4 Pharma PLC Company Financials

Assets20222021
Tangible Assets00
Intangible Assets00
Investments00
Total Fixed Assets00
Stocks00
Debtors£27,000.00£14,642.00
Cash & Equivalents£1.92 m£1.78 m
Other Assets00
Total Assets£2.17 m£2.34 m
Liabilities20222021
Creditors within 1 year£77,889.00£212,730.00
Creditors after 1 year00
Other Liabilities00
Total Liabilities£77,889.00£212,730.00
Net assets£2.09 m£2.13 m
Equity20222021
Called up share capital£935,121.00£724,321.00
Share Premium£14.70 m£13.95 m
Profit / Loss-£1.19 m-£1.84 m
Other Equity£2.09 m£2.13 m
Preference & Minorities00
Total Capital Employed£2.09 m£2.13 m
Ratios20222021
Debt Ratio00
Debt-to-Equity00
Assets / Equity1.03721.0372
Cash / Equity0.89230.8923
EPS-£0.01-£0.01
Cash Flow20222021
Cash from operating activities-£828,263.00-£1.77 m
Cashflow before financing£135,505.00-£1.77 m
Increase in Cash£135,505.00-£1.77 m
Income20222021
Turnover00
Cost of sales00
Gross Profit00
Operating Profit-£1.19 m-£1.84 m
Pre-Tax profit-£1.19 m-£1.84 m

N4 Pharma PLC Company Background

SectorHealthcare
ActivitiesN4 Pharma PLC is the holding company for N4 UK. N4 UK is a specialist pharmaceutical company engaged in the development of nanoparticle silica delivery systems to improve the cellular delivery and potency of cancer treatments and vaccines. The company operated in one business segment, that of the development and commercialisation of medicines via its delivery system called Nuvec.
Latest Interim Date12 Sep 2023
Latest Fiscal Year End Date9 Mar 2023

N4 Pharma PLC Directors

AppointedNamePosition
2017-05-03Professor Humayun Akhter MughalNon-Executive Director
2018-04-25Mr. Gavin John BurnellExecutive Director,Chief Executive Officer
2023-08-01Dr. John ChiplinNon-Executive Director,Chairman
2023-03-09Mr. Luke Sebastian Cairns Executive Director
2023-03-09Mr. Nigel TheobaldExecutive Director,Chief Executive Officer
2023-03-09Mr. David TempletonExecutive Director
2022-02-24Mr. Paul TitleyExecutive Director
2023-03-09Dr. Christopher Jonathan BrittenNon-Executive Director,Chairman

N4 Pharma PLC Contact Details

Company NameN4 Pharma PLC
Address60 Gracechurch Street, 6th Floor, London, EC3V 0HR
Telephone+44 1332690061
Websitehttps://www.n4pharma.com

N4 Pharma PLC Advisors

SolicitorDWF LLP
Phone0113 261 6000
Fax0870 094 0939
AuditorSaffery Champness
Phone+44 2078414000
Fax+44 2078414100
Financial PR AdviserAlma PR
Phone+44 2080044217
Nominated AdviserStockdale Securities Ltd
Phone+44 2076016100
StockbrokerStockdale Securities Ltd
Phone+44 2076016100
SolicitorEdwin Coe LLP
Phone+44 2076914000
Fax+44 2076914111
AuditorJeffreys Henry LLP
Phone+44 2073092222
Fax+44 2073092309
BankNational Westminster Bank PLC
StockbrokerAllenby Capital Limited
Phone+44 2033285656
Fax+44 2033942970
Financial AdviserAllenby Capital Limited
Phone+44 2033285656
Fax+44 2033942970
RegistrarNeville Registrars Ltd
Phone+44 1215851131
Fax+44 1215851132